BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Glamorous.AI

Glamorous.AI logo

Founded
2020
Geography
United Kingdom based
Funding
$0.600 M

-X-Chem, the pioneer of DNA-encoded library (DEL) technology and a recognized leader in generating actionable results to drive small molecule drug discovery, announced the acquisition of Glamorous AI. GLAMOROUS AI has developed a novel approach to chemical design and optimization. Its proprietary platform, Rosalind, augments advanced ML with human expertise to enable applications where only limited data points are available.

Technologies

AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  

R&D Platform

AI preclinical drug discovery biotech focusing on first-in-class therapeutics for challenging targets


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet